Literature DB >> 17942955

Prevalence of chronic kidney disease and survival among aboriginal people.

Song Gao1, Braden J Manns, Bruce F Culleton, Marcello Tonelli, Hude Quan, Lynden Crowshoe, William A Ghali, Lawrence W Svenson, Brenda R Hemmelgarn.   

Abstract

Globally, it is known that the incidence of end-stage renal disease is higher among Aboriginals, but it is unknown whether this is due to an increased prevalence of chronic kidney disease or other unidentified factors. We studied 658,664 people of non-First Nations and 14,989 people of First Nations and found that the age- and sex-adjusted prevalence of chronic kidney disease was significantly higher among those of non-First Nations compared to those of First Nations (67.5 versus 59.5 per 1000 population; P < 0.0001). However, severe chronic kidney disease (estimated glomerular filtration rate <30 ml/min per 1.73 m2) was almost two-fold higher among people of First Nations (P < 0.0001). Cox proportional hazards models suggested that compared to people of non-First Nations, those of First Nations with chronic kidney disease had a 77% increased risk of death after adjusting for age, gender, diabetes and baseline eGFR. In conclusion, whether the higher incidence of end-stage renal disease among people of First Nations is due to suboptimal management of chronic kidney disease and its associated comorbidities, more rapid loss of kidney function, or other unidentified factors remains to be determined.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17942955     DOI: 10.1681/ASN.2007030360

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  44 in total

1.  Adverse outcomes among Aboriginal patients receiving peritoneal dialysis.

Authors:  Manish M Sood; Paul Komenda; Amy R Sood; Martina Reslerova; Mauro Verrelli; Chris Sathianathan; Loretta Eng; Amanda Eng; Claudio Rigatto
Journal:  CMAJ       Date:  2010-07-26       Impact factor: 8.262

2.  Renal function in survivors of nonsyndromic Wilms tumor treated with unilateral radical nephrectomy.

Authors:  Rodrigo B Interiano; Noel Delos Santos; Sujuan Huang; Deo Kumar Srivastava; Leslie L Robison; Melissa M Hudson; Daniel M Green; Andrew M Davidoff
Journal:  Cancer       Date:  2015-04-01       Impact factor: 6.860

3.  CKD in disadvantaged populations.

Authors:  Guillermo Garcia-Garcia; Vivekanand Jha
Journal:  Int Urol Nephrol       Date:  2015-03-27       Impact factor: 2.370

4.  Chronic kidney disease in disadvantaged populations.

Authors:  Guillermo Garcia-Garcia; Vivekanand Jha
Journal:  Pediatr Nephrol       Date:  2014-11-14       Impact factor: 3.714

5.  CKD in disadvantaged populations.

Authors:  Guillermo Garcia-Garcia; Vivekanand Jha
Journal:  J Nephrol       Date:  2015-02       Impact factor: 3.902

Review 6.  Approach to the detection and management of chronic kidney disease: What primary care providers need to know.

Authors:  Allan K Grill; Scott Brimble
Journal:  Can Fam Physician       Date:  2018-10       Impact factor: 3.275

7.  The See Kidney Disease Targeted Screening Program for CKD.

Authors:  Lauren E Galbraith; Paul E Ronksley; Lianne J Barnieh; Joanne Kappel; Braden J Manns; Susan M Samuel; Min Jun; Rob Weaver; Nadine Valk; Brenda R Hemmelgarn
Journal:  Clin J Am Soc Nephrol       Date:  2016-05-19       Impact factor: 8.237

8.  Access to health care among status Aboriginal people with chronic kidney disease.

Authors:  Song Gao; Braden J Manns; Bruce F Culleton; Marcello Tonelli; Hude Quan; Lynden Crowshoe; William A Ghali; Lawrence W Svenson; Sofia Ahmed; Brenda R Hemmelgarn
Journal:  CMAJ       Date:  2008-11-04       Impact factor: 8.262

9.  Differential mortality and the excess burden of end-stage renal disease among First Nations people with diabetes mellitus: a competing-risks analysis.

Authors:  Ying Jiang; Nathaniel Osgood; Hyun-Ja Lim; Mary Rose Stang; Roland Dyck
Journal:  CMAJ       Date:  2013-12-02       Impact factor: 8.262

10.  Overview of the Alberta Kidney Disease Network.

Authors:  Brenda R Hemmelgarn; Fiona Clement; Braden J Manns; Scott Klarenbach; Matthew T James; Pietro Ravani; Neesh Pannu; Sofia B Ahmed; Jennifer MacRae; Nairne Scott-Douglas; Kailash Jindal; Robert Quinn; Bruce F Culleton; Natasha Wiebe; Richard Krause; Laurel Thorlacius; Marcello Tonelli
Journal:  BMC Nephrol       Date:  2009-10-19       Impact factor: 2.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.